drugset / Trial / NCT03079973

Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s

NCT03079973 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this phase III study is to evaluate the efficacy, systemic safety and local tolerability of P-3073 (calcipotriene 0.005%) nail solution in patients with mild to moderate psoriatic fingernail/s.

Timeline

Start
2017-05-15
Primary completion
2018-07
Completion
2018-07

Outcome

Outcome not reported

Stopped: “Project development priorities changed.”

Drugs

EvaluationDrugModalityDoseRoute
Subject P-3073 Unknown 0.005 % Topical

Indications